The Journal of Nutritional Biochemistry
Volume 18, Issue 12 , Pages 827-831 , December 2007

A simple rapid immunoassay for S-adenosylhomocysteine in plasma

  • Antonieta Capdevila

      Affiliations

    • Department of Biochemistry, Vanderbilt University Medical Center, Nashville, TN 37532, USA
    • ,
  • Raymond F. Burk

      Affiliations

    • Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37532, USA
    • ,
  • Joshua Freedman

      Affiliations

    • Department of Psychiatry, UCLA School of Medicine, Los Angeles, CA, USA
    • ,
  • Frank Frantzen

      Affiliations

    • Axis-Shield ASA, P.O. Box 6073, Morkved, N-8031 Bodø, Norway
    • ,
  • Ingrid Alfheim

      Affiliations

    • Bio-Medisink Innovasjon AS, Gaustadallén 21, N-0349, Oslo
    • ,
  • Conrad Wagner

      Affiliations

    • Department of Biochemistry, Vanderbilt University Medical Center, Nashville, TN 37532, USA
    • Department of Veterans Affairs Medical Center, Nashville, TN 37212, USA
    • Corresponding Author InformationCorresponding author. Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN 37232, USA. Tel.: +1 615 343 9866; fax: +1 615 343 0704.

Received 1 August 2006 ,Revised 1 December 2006 ,Accepted 3 January 2007.

References 

  1. HS Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA. 2002;288:2015–2022
  2. Bottiglieri T, Hyland K. S-adenosylmethionine levels in psychiatric and neurological disorders: a review. Acta Neurol Scand Suppl. 1994;154:19–26[Review] [53 refs]
  3. McIlroy SP, Dynan KB, Lawson JT, Patterson CC, Passmore AP. Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland. Stroke. 2002;33:2351–2356
  4. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med. 2002;346:476–483
  5. Capdevila A, Wagner C. Measurement of plasma S-adenosylmethionine and S-adenosylhomocysteine as their fluorescent isoindoles. Anal Biochem. 1998;264:180–184
  6. Kerins DM, Koury MJ, Capdevila A, Rana S, Wagner C. Plasma S-adenosylhomocysteine is a more sensitive indicator of cardiovascular disease than plasma homocysteine. Am J Clin Nutr. 2001;74:723–729
  7. Wagner C, Stone WJ, Koury MJ, Dupont WD, Kerins DM. S-adenosylhomocysteine is a more sensitive indicator of renal insufficiency than homocysteine. Nutr Res. 2004;24:487–494
  8. Jabs K, Koury MJ, Dupont WD, Wagner C. Relationship between plasma S-adenosylhomocysteine concentration and glomerular filtration rate in children. Metabolism. 2006;55:252–257
  9. Loehrer FM, Haefeli WE, Angst CP, Browne G, Frick G, Fowler B. Effect of methionine loading on 5-methyltetrahydrofolate, S-adenosylmethionine and S-adenosylhomocysteine in plasma of healthy humans. Clin Sci. 1996;91:79–86
  10. Castro R, Struys EA, Jansen EE, Blom HJ, deAlmeida IT, Jakobs C. Quantification of plasma S-adenosylmethionine and S-adenosylhomocysteine as their fluorescent 1,N(6)-etheno derivatives: an adaptation of previously described methodology. J Pharm Biomed Anal. 2002;29:963–968
  11. Struys EA, Jansen EE, deMeer K, Jakobs C. Determination of S-adenosylmethionine and S-adenosylhomocysteine in plasma and cerebrospinal fluid by stable-isotope dilution tandem mass spectrometry. Clin Chem. 2000;46:1650–1656
  12. Stabler SP, Allen RH. Quantification of serum and urinary S-adenosylmethionine and S-adenosylhomocysteine by stable-isotope-dilution liquid chromatography–mass spectrometry. Clin Chem. 2004;50:365–372
  13. Gellekink H, van Oppenraaij-Emmerzaal D, van Rooij A, Struys EA, den Heijer M, Blom HJ. Stable-isotope dilution liquid chromatography-electrospray injection tandem mass spectrometry method for fast, selective measurement of S-adenosylmethionine and S-adenosylhomocysteine in plasma. Clin Chem. 2005;51:1487–1492
  14. Frantzen F, Faaren AL, Alfheim I, Nordhei AK. Enzyme conversion immunoassay for determining total homocysteine in plasma or serum. Clin Chem. 1998;44:311–316
  15. Loehrer FM, Angst CP, Brunner FP, Haefeli WE, Fowler B. Evidence for disturbed S-adenosylmethionine: S-adenosylhomocysteine ratio in patients with end-stage renal failure: a cause for disturbed methylation reactions?. Nephrol Dial Transplant. 1998;13:656–661
  16. Sbrana E, Bramanti E, Spinetti MC, Raspi G. S-Adenosyl methionine/S-adenosyl-l-homocysteine ratio determination by capillary electrophoresis employed as a monitoring tool for the antiviral effectiveness of adenosine analogs. Electrophoresis. 2004;25:1518–1521
  17. Melnyk S, Pogribna M, Pogribny IP, Yi P, James SJ. Measurement of plasma and intracellular S-adenosylmethionine and S-adenosylhomocysteine utilizing coulometric electrochemical detection: alterations with plasma homocysteine and pyridoxal 5′-phosphate concentrations. Clin Chem. 2000;46:265–272
  18. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med. 1991;324:1149–1155
  19. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. [see comments] JAMA. 1995;274:1049–1057
  20. Yi P, Melnyk S, Pogribna M, Pogribny IP, Hine RJ, James SJ. Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation. J Biol Chem. 2000;275:29318–29323
  21. Clarke S, Banfield K. S-adenosylmethionine-dependent methyltransferases. In:  Carmel R,  Jacobsen DW editor. Homocysteine in health and disease. Cambridge, (UK): Cambridge University Press; 2001;p. 63–78
  22. James SJ, Melnyk S, Pogribna M, Pogribny IP, Caudill MA. Elevation in S-adenosylhomocysteine and DNA hypomethylation: potential epigenetic mechanism for homocysteine-related pathology. J Nutr. 2002;132:2361S–2366S
  23. Becker A, Smulders YM, Teerlink T, Struys EA, de Meer K, Kostense PJ, et al. S-adenosylhomocysteine and the ratio of S-adenosylmethionine to S-adenosylhomocysteine are not related to folate, cobalamin and vitamin B6 concentrations. Eur J Clin Invest. 2003;33:17–25
  24. The VITATOPS (Vitamins to Prevent Stroke) Trial: rationale and design of an international, large, simple, randomised trial of homocysteine-lowering multivitamin therapy in patients with recent transient ischaemic attack or stroke. Cerebrovasc Dis. 2002;13:120–126

☆ This study was supported by the Research Service of the Department of Veterans Affairs, Washington, DC, USA, and grant #DK15298 to C.W. and #ES02497 to R.F.B. from the National Institutes of Health, US Public Health Service, Bethesda, MD, USA.

PII: S0955-2863(07)00046-0

doi: 10.1016/j.jnutbio.2007.01.003

The Journal of Nutritional Biochemistry
Volume 18, Issue 12 , Pages 827-831 , December 2007

Article Tools

* Image Usage & Resolution